Word abonnee en neem Beursduivel Premium
Rode planeet als pijlen grid met hoorntjes Beursduivel

Sopheon Terug naar discussie overzicht

Sopheon mei 2022

7 Posts
| Omlaag ↓
  1. Fopje 12 mei 2022 13:27
    Als Poetin van wat erbij hem nog over is van een gezond verstand en dit gaat gebruiken om een einde te maken aan "zijn" oorlog?
  2. Bertus S 18 mei 2022 09:03
    Acquisition of Solverboard accelerates Sopheon growth strategy

    Sopheon, the leading international provider of software and services for Enterprise Innovation Management solutions, is pleased to announce the acquisition of the business and assets of Solverlink Limited (trading as Solverboard® “Solverboard”), a UK based cloud-based business specializing in the front-end of innovation management.

    Solverboard's multi-tenant, SaaS product is used by both individual innovators and product professionals, and is sold using an online, product-led growth (“PLG”) model. Solverboard brings the innovation and product needs of professionals together so that they can focus on addressing front-end innovation challenges, increasing time to value by helping companies dynamically find, align, test and deliver the best innovation and product ideas from employees and customers.

    Rationale for acquisition

    In our last annual report we noted that Sopheon will be introducing new cloud-based applications this year, providing value to individual and workgroup users in the corporate ecosystem, alongside and integrated with the group’s Accolade® enterprise software. These new applications are intended to drive lead generation for Accolade, as well as being stand-alone solutions that solve individual and workgroup productivity needs. The acquisition of Solverboard brings PLG capabilities into Sopheon more rapidly than previously planned, and accelerates this SaaS strategy from both functional and go-to-market perspectives. Sopheon will continue to offer a free version of Solverboard and a paid subscription with more advanced features. We expect to introduce additional Sopheon products to be sold through the Solverboard channel by the end of the year.

    Deal structure and consideration

    The transaction is structured as a business and asset purchase. Initial consideration comprises £500,000 in cash and £250,000 in shares issued at £6 per share. An additional, contingent deferred earn-out of up to £1.55 million is payable over the next two years, linked to Annual Recurring Revenue (“ARR”) targets. The earn-out consideration will be satisfied by up to £900,000 in shares issued at £6 per share, with the balance in cash. The cash consideration component of the acquisition is being funded out of existing and healthy cash resources. The share consideration elements are subject to lock in and orderly market restrictions.

    Since inception, over £3 million has been invested in the Solverboard business and products by Solverboard’s founders and management. A new platform was launched in September 2021, and has secured a number of customers to its free tier but is yet to generate material revenues. The costs of the business will be absorbed into Sopheon’s current operating plans, through the reprioritization of planned spend.

    Greg Coticchia, CEO of Sopheon said: “This acquisition is another step in our mission to provide the most comprehensive innovation system for the world’s best companies. As well as its functional capabilities in the front end of innovation, adding Solverboard’s expertise immediately brings us deep PLG go-to-market capabilities that were on our development roadmap. This is the second acquisition of a cloud-native, multi-tenant SaaS solution by Sopheon in the past six months. We look to the Solverboard and ROI Blueprints acquisitions to accelerate Sopheon’s shift to a pure play SaaS model and associated ARR growth.”

    Solverboard founder and CEO Phil Atherton added: “It is very exciting to become part of Sopheon, a leader in the Enterprise Innovation Management space. Our companies are a perfect fit in vision, purpose and culture. Solverboard’s product-led “go to market” capability for innovation and product professionals is highly complementary to Sopheon’s market-leading sales-led enterprise go-to-market capability. We believe this combination will be pretty unique in our sector.”


    Allotment and issue of shares

    Sopheon has allotted 41,667 new Ordinary Shares of 20 pence each in the Company to satisfy the share component of the initial consideration. Application will be made for the new Ordinary Shares to be admitted to trading on AIM and dealings are expected to commence on 23 May 2022. The new Ordinary Shares will rank pari-passu with the Company's existing Ordinary Shares. The total number of Ordinary Shares in issue following Admission will be 10,594,992. The Company does not hold any shares in treasury. Accordingly, the figure of 10,594,992 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the FCA's Disclosure Guidance and Transparency Rules.

    www.sopheon.com/financial-releases/ac...

    Bertus S.
  3. Gartje 19 mei 2022 18:30
    Pff om moedeloos van te worden dit fonds soms, maar de toekomst in de wereld is helaas nog bedroevender. Dus maar weer een jaar afschrijven en hopen op ....
  4. marblesthegame 27 mei 2022 18:28
    23 May 2022

    For immediate release

    SOPHEON PLC
    ("Sopheon" or the "Company")

    Director Share Purchase - Issue of Equity

    Sopheon, the international provider of software and services for Enterprise Innovation Management solutions, announces that, following the exercise of options by an employee, it has allotted 15,112 new Ordinary Shares of 20 pence each in the Company ("Ordinary Shares"). Application will be made for the new Ordinary Shares to be admitted to trading on AIM and dealings are expected to commence on 26 May 2022.

    Greg Coticchia, the Company's CEO, acquired 5,100 of these shares at a price of £5.45 per share being the closing price on Friday 20 May 2022. Following this transaction, Mr Coticchia's total beneficial interest in Ordinary Shares is 5,100 Ordinary Shares. The remaining 10,012 shares were purchased by the Company's Employee Benefit Trust.

    The new Ordinary Shares will rank pari passu with the Company's existing Ordinary Shares. The total number of Ordinary Shares in issue following Admission will be 10,610,104. The Company does not hold any shares in treasury. Accordingly, the figure of 10,610,104 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the FCA's Disclosure Guidance and Transparency Rules.
7 Posts
|Omhoog ↑

Neem deel aan de discussie

Word nu gratis lid van Beursduivel.be

Al abonnee? Log in

Direct naar Forum

Zoek alfabetisch op forum

  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
Forum # Topics # Posts
Aalberts 465 6.840
AB InBev 2 5.286
Abionyx Pharma 2 29
Ablynx 43 13.356
ABN AMRO 1.580 46.452
ABO-Group 1 19
Acacia Pharma 9 24.692
Accell Group 151 4.129
Accentis 2 253
Accsys Technologies 22 8.942
ACCSYS TECHNOLOGIES PLC 218 11.686
Ackermans & van Haaren 1 160
ADMA Biologics 1 31
Adomos 1 126
AdUX 2 457
Adyen 13 16.471
Aedifica 2 832
Aegon 3.257 320.091
AFC Ajax 537 7.018
Affimed NV 2 5.761
ageas 5.843 109.778
Agfa-Gevaert 13 1.862
Ahold 3.536 73.983
Air France - KLM 1.024 34.348
Airspray 511 1.258
Akka Technologies 1 18
AkzoNobel 466 12.774
Alfen 12 16.530
Allfunds Group 3 1.217
Almunda Professionals (vh Novisource) 651 4.247
Alpha Pro Tech 1 17
Alphabet Inc. 1 337
Altice 106 51.196
Alumexx ((Voorheen Phelix (voorheen Inverko)) 8.485 114.765
AM 228 684
Amarin Corporation 1 133
Amerikaanse aandelen 3.821 240.357
AMG 965 125.842
AMS 3 73
Amsterdam Commodities 303 6.522
AMT Holding 199 7.047
Anavex Life Sciences Corp 2 382
Antonov 22.632 153.605
Aperam 91 14.161
Apollo Alternative Assets 1 17
Apple 5 315
Arcadis 251 8.623
Arcelor Mittal 2.024 318.661
Archos 1 1
Arcona Property Fund 1 267
arGEN-X 15 9.112
Aroundtown SA 1 176
Arrowhead Research 5 9.283
Ascencio 1 20
ASIT biotech 2 697
ASMI 4.107 37.700
ASML 1.762 77.051
ASR Nederland 18 4.122
ATAI Life Sciences 1 7
Atenor Group 1 333
Athlon Group 121 176
Atrium European Real Estate 2 199
Auplata 1 55
Avantium 29 10.666
Axsome Therapeutics 1 177
Azelis Group 1 49
Azerion 7 2.681

Beleggingsideeën van onze partners

Macro & Bedrijfsagenda

  1. 03 mei

    1. Chinese beurzen gesloten ivm Labor Day
    2. Aperam Q1-cijfers
    3. Bpost Q1-cijfers
    4. Credit Agricole Q1-cijfers
    5. Ontex -Q1-cijfers
    6. Brunel Q1-cijfers
    7. Heijmans €0,89 ex-dividend
    8. VS banengroei en werkloosheid april Banengroei: 243K. Werkloosheid: 3,8%. Uurlonen: +0,3% MoM volitaliteit verwacht
    9. VS inkoopmanagersindex diensten S&P april (def)
    10. VS Inkoopmanagersindex diensten ISM april (def)
de volitaliteit verwacht indicator betekend: Market moving event/hoge(re) volatiliteit verwacht